What specific aspects of regulatory processes or procedures can regulatory agencies improve to make regulatory oversight for products of biotechnology more transparent, coordinated, predictable, and efficient while continuing their primary role(s)? What specific information can regulatory agencies, or other agencies and offices, provide to biotechnology product developers, especially small businesses, to assist in their efforts to navigate the regulatory system?

More Lars Lafferty's questions See All
Similar questions and discussions